RxDoctor Payments Data

Chike Obianwu, MD

Obstetrics & Gynecology · Delran, NJNPI 1902984909

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 219 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 36 manufacturers reported payments, led by AbbVie at 30.1% of the total. Reporting peaked in 2022 at $867 and has fallen 62.5% since, to $325 in 2025. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,980in general payments, 2019–2025

Across 219 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Astellas Pharma US Inc$349
  • Myovant Sciences Inc.$164
  • Sumitomo Pharma America, Inc.$160
  • Mylan Pharmaceuticals Inc.$147
  • Pacira Pharmaceuticals Incorporated$139
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$3,85597%
  • Education$1253%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,980 in reported general payments places this provider in the 90th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$28,825
Medicare patients
86
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol28$1,009
ValacyclovirValacyclovir Hcl16$503
ProgesteroneProgesterone, Micronized25$488
Medroxyprogesterone Acetate11$409
Fluconazole29$157
Gabapentin17$116
Ibuprofen21$103
Metronidazole12$42

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Delran

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →